UNSPSC 85255402: Diagnosis of benign neoplasm on the renal pelvis

This classification denotes the group of activities that yields a diagnosis of Benign neoplasm on the Renal pelvis. Benign neoplasm on the Renal pelvis is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D30.1

UNSPSC 85255402, Diagnosis of benign neoplasm on the renal pelvis, is a Commodity code that shows minimal alignment with recent state and local procurement activity. The source contains three recent opportunities tagged under this code, but only one—the San Mateo Medical Center PACS (Picture Archiving and Communication System) solicitation—relates tangentially to diagnostic imaging infrastructure; the other two (Birdville Independent School District special education contracted services and Santa Clara Health System temporary health professional staffing) do not address renal or oncologic diagnosis and appear misclassified. The SMMC opportunity involves enterprise-grade diagnostic imaging system implementation supporting radiology, cardiology, and dental imaging with EPIC integration, but focuses on PACS platform selection and data migration rather than clinical diagnostic protocols for benign renal neoplasms specifically. This mismatch suggests the code does not capture active state and local procurement for clinical diagnostic services in urology or nephrology.

The issuing bodies in the source span a county health system (San Mateo Medical Center), a large independent school district (Birdville ISD in Texas), and a regional health system (Santa Clara County), representing mixed public health and education jurisdictions in California and Texas. The single imaging-related solicitation—San Mateo Medical Center's PACS RFP with a response date of October 21, 2026—involves system implementation rather than diagnostic services procurement. No recent opportunities under this code reflect actual demand for diagnostic pathways, specialist consultations, or clinical evaluation services for benign renal neoplasms in state or local healthcare procurement.